Harrison Jr, Miles G MD

Located in Baltimore MD you can find the skilled expertise of Camellus O Ezeugwu MD at Just Heart Cardiovascular Group. Specializing in General/Allopathic Medicine Dr. Ezeugwu holds the prestigious title of M.D. (Doctor of Medicine). With a wealth of knowledge and experience this medical doctor is dedicated to providing top-notch care to their patients. At Just Heart Cardiovascular Group patients can trust Dr. Ezeugwu's expertise in general medicine to address a wide range of health concerns. Whether it's a routine check-up or a complex medical issue this physician is committed to delivering compassionate and comprehensive care. With a focus on cardiovascular health Dr. Ezeugwu brings a unique blend of skill and empathy to every patient interaction ensuring that individuals receive the highest quality medical attention. Generated from this place's public information

SNBL, also known as Shin Nippon Biomedical Laboratories, is one of the largest contract research organizations located in Japan. The company operates cardiovascular, respiratory, gastrointestinal, urology, dermatology, oncology, antihistaminic, biological and alternative medicine departments. It specializes in real time reporting, advanced data management and quality assurance services. SNBL features a 96-bed inpatient facility that includes blood pressure, temperature, pulse oximetry and heart monitoring machines. Its subsidiary, SNBL CPC has a staff of trained and certified research physicians and neurologists. The company has a partnership with UPM Pharmaceuticals, which is an independent drug development and contract manufacturing company serving the pharmaceutical and biotechnology industries. Its outpatient facility operates several examination and phlebotomy rooms. SNBL is located in Baltimore.

The Institute of Human Virology (IHV) at the University of Maryland is a pioneering research institution that focuses on innovative therapies for HIV/AIDS and other chronic viral diseases. Combining basic science with population studies and clinical trials, IHV aims to develop new vaccines and treatments, contributing significantly to the fight against one of the deadliest pandemics in modern history. In addition to its research initiatives, IHV provides compassionate, cutting-edge care to approximately 5,000 patients through clinics in the Baltimore area, as well as serving over 500,000 patients across seven African nations and two Caribbean nations. The institute specializes in the treatment of HIV/AIDS, Hepatitis C, Hepatitis B, and the Human Papilloma Virus Infection, ensuring comprehensive healthcare solutions for those affected. Generated from the website